Shawn McCormick Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shawn McCormick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shawn McCormick. Shawn McCormick is Director in SURMODICS INC ($SRDX) and Sr. VP and CFO in ev3 Inc. ($EVVV) and Director in ENTELLUS MEDICAL INC ($ENTL) and Director in NEVRO CORP ($NVRO) and Chief Financial Officer in Wright Medical Group N.V. ($TRNX) and Director in Inspire Medical Systems, Inc. ($INSP).
Latest Insider Trading Transactions of Shawn McCormick
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ENTL, EVVV, INSP, NVRO, SRDX, TRNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2021 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,167 | 0 | 8,457 | 7.3 K to 8.5 K (+16.01 %) |
May 26 2021 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 149.65 | 482 | 72,131 | 7,290 | 7.8 K to 7.3 K (-6.20 %) |
May 03 2021 | INSP | Inspire Medical Sy ... | McCormick Shawn | Director | Option Exercise | A | 240.68 | 1,175 | 282,799 | 1,175 | |
May 26 2020 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 126.50 | 1,020 | 129,030 | 7,772 | 8.8 K to 7.8 K (-11.60 %) |
May 26 2020 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,376 | 0 | 8,792 | 7.4 K to 8.8 K (+18.55 %) |
May 04 2020 | INSP | Inspire Medical Sy ... | McCormick Shawn | Director | Option Exercise | A | 71.66 | 3,501 | 250,882 | 3,501 | |
Feb 18 2020 | SRDX | SURMODICS INC | McCormick Shawn | Director | Option Exercise | A | 39.58 | 4,218 | 166,948 | 4,218 | |
Feb 18 2020 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 0.00 | 1,452 | 0 | 9,210 | 7.8 K to 9.2 K (+18.72 %) |
Nov 13 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 104.35 | 800 | 83,480 | 7,416 | 8.2 K to 7.4 K (-9.74 %) |
Nov 13 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 104.35 | 800 | 83,480 | 7,416 | 8.2 K to 7.4 K (-9.74 %) |
May 22 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 2,913 | 0 | 8,216 | 5.3 K to 8.2 K (+54.93 %) |
May 06 2019 | INSP | Inspire Medical Sy ... | McCormick Shawn | Director | Option Exercise | A | 49.96 | 4,569 | 228,267 | 4,569 | |
Feb 15 2019 | SRDX | SURMODICS INC | McCormick Shawn | Director | Option Exercise | A | 55.24 | 2,605 | 143,900 | 2,605 | |
Feb 15 2019 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 0.00 | 859 | 0 | 7,758 | 6.9 K to 7.8 K (+12.45 %) |
Jan 03 2019 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 47.26 | 133 | 6,286 | 6,899 | 6.8 K to 6.9 K (+1.97 %) |
Oct 02 2018 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 74.65 | 84 | 6,271 | 6,766 | 6.7 K to 6.8 K (+1.26 %) |
Jul 03 2018 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 55.20 | 114 | 6,293 | 6,682 | 6.6 K to 6.7 K (+1.74 %) |
May 23 2018 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 3,785 | 0 | 5,303 | 1.5 K to 5.3 K (+249.34 %) |
May 09 2018 | INSP | Inspire Medical Sy ... | McCormick Shawn | Director | Option Exercise | A | 16.00 | 17,296 | 276,736 | 17,296 | |
May 09 2018 | INSP | Inspire Medical Sy ... | McCormick Shawn | Director | Buy | P | 16.00 | 3,000 | 48,000 | 3,000 | 0 to 3 K |
Apr 03 2018 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 38.05 | 165 | 6,278 | 6,568 | 6.4 K to 6.6 K (+2.58 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | McCormick Shawn | Director | Option Exercise | D | 13.38 | 5,000 | 66,900 | 0 | |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | McCormick Shawn | Director | Option Exercise | D | 18.26 | 10,000 | 182,600 | 0 | |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | McCormick Shawn | Director | Option Exercise | D | 11.36 | 15,000 | 170,400 | 0 | |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | McCormick Shawn | Director | Sell | D | 24.00 | 5,441 | 130,584 | 0 | 5.4 K to 0 (-100.00 %) |
Feb 22 2018 | SRDX | SURMODICS INC | McCormick Shawn | Director | Option Exercise | A | 27.30 | 5,275 | 144,008 | 5,275 | |
Feb 22 2018 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 0.00 | 1,739 | 0 | 6,403 | 4.7 K to 6.4 K (+37.29 %) |
Jun 14 2017 | ENTL | ENTELLUS MEDICAL I ... | McCormick Shawn | Director | Option Exercise | A | 13.38 | 5,000 | 66,900 | 5,000 | |
Jun 14 2017 | ENTL | ENTELLUS MEDICAL I ... | McCormick Shawn | Director | Grant | A | 0.00 | 2,500 | 0 | 5,441 | 2.9 K to 5.4 K (+85.01 %) |
May 30 2017 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
May 30 2017 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,518 | 0 | 1,518 | 0 to 1.5 K |
Feb 16 2017 | SRDX | SURMODICS INC | McCormick Shawn | Director | Option Exercise | A | 23.95 | 3,932 | 94,171 | 3,932 | |
Feb 16 2017 | SRDX | SURMODICS INC | McCormick Shawn | Director | Option Exercise | A | 23.95 | 3,932 | 94,171 | 3,932 | |
Feb 16 2017 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 0.00 | 1,252 | 0 | 4,664 | 3.4 K to 4.7 K (+36.69 %) |
Feb 16 2017 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 0.00 | 1,252 | 0 | 4,664 | 3.4 K to 4.7 K (+36.69 %) |
Jan 04 2017 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 25.40 | 447 | 11,354 | 3,412 | 3 K to 3.4 K (+15.08 %) |
Oct 04 2016 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 30.09 | 378 | 11,374 | 2,965 | 2.6 K to 3 K (+14.61 %) |
Jul 05 2016 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 23.48 | 484 | 11,364 | 2,587 | 2.1 K to 2.6 K (+23.01 %) |
Jul 05 2016 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 23.48 | 484 | 11,364 | 2,587 | 2.1 K to 2.6 K (+23.01 %) |
Jul 05 2016 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 23.48 | 484 | 11,364 | 2,587 | 2.1 K to 2.6 K (+23.01 %) |
Jun 15 2016 | ENTL | ENTELLUS MEDICAL I ... | McCormick Shawn | Director | Option Exercise | A | 18.26 | 10,000 | 182,600 | 10,000 | |
May 20 2016 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
Apr 04 2016 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 18.41 | 617 | 11,359 | 2,103 | 1.5 K to 2.1 K (+41.52 %) |
Dec 22 2015 | SRDX | SURMODICS INC | McCormick Shawn | Director | Option Exercise | A | 20.18 | 4,366 | 88,106 | 4,366 | |
Dec 22 2015 | SRDX | SURMODICS INC | McCormick Shawn | Director | Grant | A | 0.00 | 1,486 | 0 | 1,486 | 0 to 1.5 K |
Oct 05 2015 | TRNX | Wright Medical Gro ... | McCormick Shawn | Chief Financial Off ... | Payment of Exercise | F | 20.67 | 8,472 | 175,116 | 36,034 | 44.5 K to 36 K (-19.04 %) |
Jun 05 2015 | TRNX | Wright Medical Gro ... | McCormick Shawn | Chief Financial Off ... | Sell | S | 26.50 | 3,693 | 97,853 | 44,506 | 48.2 K to 44.5 K (-7.66 %) |
Jun 01 2015 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 | |
Jan 20 2009 | EVVV | ev3 Inc. | McCormick Shawn | Sr. VP and CFO | Option Exercise | A | 6.23 | 140,000 | 872,200 | 140,000 | |
Jan 20 2009 | EVVV | ev3 Inc. | McCormick Shawn | Sr. VP and CFO | Grant | A | 0.00 | 56,000 | 0 | 56,000 | 0 to 56 K |
Page: 1